Multimodal Analysis of Endomyocardial Biopsies
Recruiting
Observational Study
Heart Transplantation
Dilated Cardiomyopathy (DCM)
Hypertrophic Cardiomyopathy (HCM)
Myocarditis, Pericarditis
Amyloidosis Cardiac
Cardiomyopathies
Sarcoidosis of the Heart
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 216 (estimated)
- Sponsor
- University Hospital, Essen · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational study is to pursue a multimodal approach to identify the molecular signatures and immune signalling molecules of various myocardial diseases and thereby contribute to improving diagnosis and therapy.
The main aim is:
-Identification of molecular profiles (e.g., proteome, lipidome, metabolome) and immune signalling profiles that are specifically associated with diff…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients aged \>18 years with a clinical indication for endomyocardial biopsy.
* Patients capable of providing informed consent who have signed the consent form for participation in the study.
Exclusion Criteria:
* Patients without a clinical indication for endomyocardial bi…
Contacts